This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20190711005424/en/
Technavio has released a new market research report on the global absorbable sutures market from 2019-2023. (Graphic: Business Wire) Veterinary Services
The global absorbable sutures market is highly competitive with major vendors such as B. Braun Melsungen AG, Boston Scientific Corporation, DemeTECH Corporation, Johnson & Johnson Services Inc., Medtronic, and Teleflex Incorporated, competing based on price, quality, and market presence.
“Absorbable sutures provide tensile strength till the tissue regains strength, and then it dissolves completely through proteolytic enzymatic degradation. These advantages of absorbable sutures will fuel the market growth during the forecast period,” says a senior analyst at Technavio.
Top five absorbable sutures market vendors
B. Braun Melsungen AG owns and operates businesses in four major segments that include hospital care, aesculap, OPM, and B. Braun avitum. Under its absorbable sutures category, the company offers various products including monosyn, novosyn, monomax, monosyn quick, novosyn quick, monoplus, and safil.
Boston Scientific Corporation is one of the leading companies in the healthcare sector that has operations in various segments, including cardiovascular, rhythm and neuro, and medsurg. The company offers capio sutures that include both absorbable and non-absorbable sutures. Under absorbable sutures, the company offers two products, namely, absorbable sutures coated with PGA, and monodek absorbable sutures.
DemeTECH Corporation provides a wide range of sutures, namely DemeSORB, DemeCRYL, DemeQUICK, DemeDIOX, DemeCAPRONE, DemeGUT, and DemeGUT PLAIN. The company’s DemeQUICK is a rapid absorbable surgical suture which is a coated, braided synthetic absorbable suture and is composed of copolymers made from 90% glycolide and 10% L-lactide.
Johnson & Johnson Services Inc.
Johnson & Johnson Services Inc. is one of the most popular companies across the world, with business operations in pharmaceutical, medical devices, and consumer products segments. The company provides coated VICRYL (polyglactin 910) suture, a synthetic absorbable sterile surgical suture, which is composed of a copolymer made from 90% glycolide and 10% L-lactide.
Medtronic has business operations in four major segments that include cardiac and vascular; minimally invasive therapies; restorative therapies; and diabetes. Under its absorbable sutures category, the company provides four main products, namely, velosorb fast, caprosyn, polysorb, and biosyn.
Looking for more information on this market? Request a free sample report
Technavio’s sample reports are free of charge and contain multiple sections of the report, including the market size and forecast, drivers, challenges, trends, and more.
Technavio is a leading global technology research and advisory company. Their research and analysis focuses on emerging market trends and provides actionable insights to help businesses identify market opportunities and develop effective strategies to optimize their market positions.
With over 500 specialized analysts, Technavio’s report library consists of more than 10,000 reports and counting, covering 800 technologies, spanning across 50 countries. Their client base consists of enterprises of all sizes, including more than 100 Fortune 500 companies. This growing client base relies on Technavio’s comprehensive coverage, extensive research, and actionable market insights to identify opportunities in existing and potential markets and assess their competitive positions within changing market scenarios.
If you are interested in more information, please contact our media team at media@technavio.com.
View source version on businesswire.com: https://www.businesswire.com/news/home/20190711005424/en/
Technavio Research Jesse Maida Media & Marketing Executive US: +1 844 364 1100 UK: +44 203 893 3200 technavio.com media@technavio.com
Technavio has released a new market research report on the global absorbable sutures market from 2019-2023. (Graphic: Business Wire)
View this news release and multimedia online at: http://www.businesswire.com/news/home/20190711005424/en
Pglapolyglactin 910 © 1985 - 2024 BioSpace.com. All rights reserved. Powered by Madgex Job Board Software